Menu

Report Library

All Reports
2014 BioMedTracker Pre-AASLD Report
*Included free with BioMedTracker Subscription - click here to log in

October 09, 2014

BioMedTracker will be offering numerous medical meeting conference planners through 2014 for purchase a la carte, or in a bundle of several select conferences. For more information on conference availability and pricing, please email BioMedTracker or call BioMedTracker Client Services at (858) 200- 2357. The 65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) 2014 will be held in Boston, MA from November 7-11. We have assembled a sortable, pre-meeting planner listing all presentation titles and affiliated drugs/companies. Additionally, we have highlighted abstracts of interest in Hepatitis C, Hepatitis B, and Non-Alcoholic Steatohepatitis (NASH) and included estimated approval timelines for promising drugs in mid to late-stage development. A list of meeting catalysts is included at the end of the report as well as high impact catalysts through the first half of 2015. Updated 10/08/14: Late breaking abstract highlights and an in-depth trial analysis performed by Citeline for HCV, HBV, and NASH were added to this BioMedTracker Pre-AASLD Report. We will also be reporting on and analyzing events live from the AASLD conference with a BMT Post-AASLD Report following the meeting. If there are specific talks, posters, or topics you would like us to follow, or if you would like a copy of the planner in Excel, please e-mail clientservices@pharmaintel.informa.com or call your sales representative. For the full report, please download the PDF version at the top of this page or contact your sales representative. For our disclosures, please read the BioMedTracker Research Standards.
Indications Covered: Diabetes Mellitus, Type I
Diabetes Mellitus, Type II
Diabetic Nephropathy
Hepatic Encephalopathy (HE)
Hepatic Fibrosis
Hepatitis B (HBV) Treatment (Antiviral)
Hepatitis B Prevention (Vaccines, Antiviral)
Hepatitis C (HCV) (Antiviral)
Hepatitis C Prevention (Vaccines, Antiviral)
Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases)
Liver Failure / Cirrhosis
Non-Alcoholic Steatohepatitis (NASH)
Obesity
Solid Tumors